Raclopride-PET/MRT

NCT03637075 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

OTHER: intranasal insulin
OTHER: Placebo

Sponsor

University Hospital Tuebingen